exenatide glp 1 agonist GLP1 receptor @nejm revisión Indications for GLP-1/GIP RA Summary

The assessment of changes in psychopathology represents a relevant area of investigation, particularly in light of the interaction between GLP-1 and the cholinergic and dopamine-derived motivational system [39] and the established association between obesity and psychopathology [40]

Thus, variations of each single factors could potentially explain the discrepancies observed in the different studies (66)

Pharmaceutical companies have been trying to produce small-molecule GLP-1 agonists that are shelf-stable and can be taken orallyfor instance, Pfizer and Eli Lilly have developed Danuglipron and Orforglipron, respectivelybut we know very little about how they work, said Ali Gler, a neuroscientist at the University of Virginia

Particularly, when a high dose (5.4 mg/kg) of LY3502970 was given, the insulin secretion was comparable to that induced by exenatide, and an anorexigenic effect was achieved with just 0.05 mg/kg of LY3502970

This may suggest that the observation of a benefit of the GLP-1 RAs on heart failure hospitalisation as found in the meta-analysis by Sattar and colleagues is driven by data from AMPLITUDE-O and Harmony Outcomes

This research aimed to investigate how miR-192 affects pancreatic -cell development